eafert.blogg.se

• Vaccine stockpile plus#

The Advance Purchase Agreement with BioNTech-Pfizer provided for the initial purchase of 200 million doses on behalf of all EU Member States, plus an option to purchase up to a further 100 million doses. This followed a positive scientific recommendation by the European Medicines Agency. On 21 December 2020, the Commission granted a conditional marketing authorisation for the COVID‑19 vaccine developed by BioNTech and Pfizer, making it the first COVID-19 vaccine authorised in the EU. Safe and effective vaccines started to be distributed in the EU by the end of 2020, following strict authorisation procedures and the highest safety standards. The vaccine strategy should act as a reference point for Member States when formulating their national vaccination strategies. to make sure that preparations are made in EU countries regarding the roll-out of safe and effective vaccines, addressing transportation and deployment needs, and identifying priority groups.to ensure equitable and affordable access for all in the EU to an affordable vaccine as early as possible.to secure timely access to vaccines for Member States and their population while leading the global solidarity effort.to ensure the quality, safety and efficacy of vaccines.The objectives of the EU Vaccines Strategy are: With the vaccines strategy, the Commission supported efforts to make the process more efficient, resulting in this timeframe being reduced to less than one year for most vaccines. On 17 June 2020, the European Commission presented the EU Vaccines Strategy to accelerate the development, manufacturing and deployment of vaccines against COVID-19. This funding was considered a down-payment on the vaccines that Member States purchase. In return, the Commission financed a part of the upfront costs from the €2.7 billion Emergency Support Instrument. Through Advance Purchase Agreements with individual vaccine producers, the Commission secured the right to buy a specified number of vaccine doses in a given timeframe and at a given price.

The Commission and Member States have taken a common EU approach to securing supplies and facilitating their distribution. Safe and effective vaccines against COVID-19 are the best way out of the pandemic.